Low dose oral idarubicin in combination with cyclophosphamide and dexamethasone (CID) for management of melphalan-prednisolone (MP) resistant myeloma

Citation
S. Kashyap et al., Low dose oral idarubicin in combination with cyclophosphamide and dexamethasone (CID) for management of melphalan-prednisolone (MP) resistant myeloma, LEUK LYMPH, 33(3-4), 1999, pp. 407-408
Citations number
5
Categorie Soggetti
Hematology,"Onconogenesis & Cancer Research
Journal title
LEUKEMIA & LYMPHOMA
ISSN journal
10428194 → ACNP
Volume
33
Issue
3-4
Year of publication
1999
Pages
407 - 408
Database
ISI
SICI code
1042-8194(199904)33:3-4<407:LDOIIC>2.0.ZU;2-#